Contact Information: Contact: Lisa Scimemi Cambridge Healthtech Institute Email Contact 781-972-5419
Strategic Planning for Discovery, Development and Clinical Operations in China, India and Other Emerging Regions
| Source: Cambridge Healthtech Institute
NEEDHAM, MA -- (MARKET WIRE) -- February 16, 2007 -- The Pharmaceutical Strategy Series (PSS), a
division of Cambridge Healthtech Institute, posted details for its Global
R&D Congress, May 15-16, 2007, Park Hyatt Hotel in Philadelphia, PA.
Speakers and delegates from PSS's annual China and India conferences, as
well as those involved in projects in Asia, Russia, Eastern Europe and
Latin America, will discuss the opportunities and challenges of drug
discovery and development in emerging regions.
"We are extremely pleased to present this conference to the industry," said
Micah Lieberman, Conference Director for the Pharmaceutical Strategy Series
and conference chairperson. "PSS conducted months of research and
interviews with R&D executives; and based on our findings, we've developed
a comprehensive event for bio/pharmaceutical companies to successfully
expand and/or develop their R&D operations overseas. Basic research and
discovery, preclinical development, and clinical operations will be
carefully reviewed so our delegates' companies can start reaping the full
benefits of outsourcing R&D in Asia."
The Global R&D Congress brings together an impressive roster of speakers
representing US FDA, Merck, Wyeth, Biogen Idec, Bristol-Myers Squibb,
Johnson & Johnson, to name a few, who will participate in case studies and
panel discussions. Participants will attend a complimentary pre-conference
tutorial, Planning a Global Strategy Around Intellectual Property Law: IP
Barriers, and Trends, to be led by Greg Kalbaugh, US-India Business Council
and Mak Jawadekar, Ph.D., Pfizer.
More on the Global R&D Congress can be found at
www.healthtech.com/2007/PCG.
About the Pharmaceutical Strategy Series
The Pharmaceutical Strategy Series (PSS) is a division of Cambridge
Healthtech Institute. PSS programs have been designed to help the R&D
leaders and corporate executives assess business opportunities, enhance
corporate value and forecast the economic and regulatory landscape within
the rapidly changing pharmaceutical & biotechnology industries. PSS chooses
the most topical issues to cover, based largely on advice given by the PSS
Advisory Board. The Advisory Board is comprised of decision-makers at most
of the world's leading pharmaceutical companies. Presentations in each
Executive Forum will give you the ideas, information, and resources you
need to make faster and smarter decisions. www.pharmaseries.com
About Cambridge Healthtech Institute
Cambridge Healthtech Institute's renowned conferences are the underpinning
for all our other information resources. Each year, CHI organizes over 80
conferences held throughout the US, including the Molecular Medicine
Tri-Conference, Beyond Genome, PepTalk: The Protein Information Week, World
Pharmaceutical Congress and the newly acquired Bio-IT World Conference &
Expo. The company strives to develop quality programs that provide valuable
new insights and competing points of view while offering balanced coverage
of the latest developments. Basic research related to commercial
implications is covered, with heavy emphasis placed on end-user insights
into new products and technology as well as coverage on the strategy behind
the business. Leading researchers and business experts from top
pharmaceutical, biotech and academic organizations present their most
current findings in a forum that features panel discussions and audience
participation. Over the past 14 years, CHI has produced more than 600
conferences, attracting more than 50,000 attendees from around the world.
www.healthtech.com